AI Assistant
Blog
Pricing
Log In
Sign Up
Correction: HDAC7 is an actionable driver of therapeutic antibody resistance by macrophages from CLL patients
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
